Gilead Sciences, Inc. (GILD)
NASDAQ·Healthcare·Drug Manufacturers - General
$125.39
-0.37%
Mkt Cap $160.36B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (90 analysts)
$158.71
Range $105.00 – $180.00
Implied Upside
+26.6%
Consensus $158.71 vs current $125.39